Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 14062-24-9 | MDL No. : | MFCD00018791 |
Formula : | C10H11ClO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UTWBWFXECVFDPZ-UHFFFAOYSA-N |
M.W : | 198.65 | Pubchem ID : | 84177 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.3 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 52.12 |
TPSA : | 26.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.45 cm/s |
Log Po/w (iLOGP) : | 2.31 |
Log Po/w (XLOGP3) : | 2.91 |
Log Po/w (WLOGP) : | 2.45 |
Log Po/w (MLOGP) : | 2.84 |
Log Po/w (SILICOS-IT) : | 3.03 |
Consensus Log Po/w : | 2.71 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.98 |
Solubility : | 0.207 mg/ml ; 0.00104 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.12 |
Solubility : | 0.15 mg/ml ; 0.000753 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.9 |
Solubility : | 0.0248 mg/ml ; 0.000125 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.64 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | Stage #1: With lithium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.5 h; Stage #2: at -78 - 20℃; |
General procedure: To a stirred solution of phenyl acetic acid ethyl ester 1a (1 g, 6.09 mmol) in THF (10 mL) was added LiHMDS (9.1 ml, 1 M sol. in THF, 7.31 mmol) at -78 °C and the reaction mixture was stirred at this temperature for 30 min. Ethyl-1-imidazole carboxylate 2 (1.2 g, 9.146 mmol) in dry THF (3 ml) was added drop wise to the reaction mixture at -78 °C and stirred at rt for 3 h. The reaction mixture was quenched with saturated ammonium chloride solution and extracted with ethyl acetate. The combined organic layer was washed with water, saturated brine solution, and dried over Na2SO4. The solvent was evaporated under reduced pressure and the crude product was chromatographed on a silica gel column. Elution with 4percent ethyl acetate/pet ether gave the pure compound 3a (1.1 g, 81percent yield) as a colorless liquid. |
[ 40061-54-9 ]
Ethyl 2-(2-chlorophenyl)acetate
Similarity: 0.96
[ 200214-60-4 ]
Ethyl 2-(3,5-dichlorophenyl)acetate
Similarity: 0.96
[ 53088-68-9 ]
Methyl (3-Chlorophenyl)acetate
Similarity: 0.94
[ 1329489-84-0 ]
Methyl 2-(4'-chloro-[1,1'-biphenyl]-2-yl)acetate
Similarity: 0.92
[ 40061-54-9 ]
Ethyl 2-(2-chlorophenyl)acetate
Similarity: 0.96
[ 200214-60-4 ]
Ethyl 2-(3,5-dichlorophenyl)acetate
Similarity: 0.96
[ 53088-68-9 ]
Methyl (3-Chlorophenyl)acetate
Similarity: 0.94
[ 1329489-84-0 ]
Methyl 2-(4'-chloro-[1,1'-biphenyl]-2-yl)acetate
Similarity: 0.92
[ 40061-54-9 ]
Ethyl 2-(2-chlorophenyl)acetate
Similarity: 0.96
[ 200214-60-4 ]
Ethyl 2-(3,5-dichlorophenyl)acetate
Similarity: 0.96
[ 53088-68-9 ]
Methyl (3-Chlorophenyl)acetate
Similarity: 0.94
[ 1329489-84-0 ]
Methyl 2-(4'-chloro-[1,1'-biphenyl]-2-yl)acetate
Similarity: 0.92